Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05079230 |
| Consolidated Lead Sponsor | Gilead Sciences |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 378 participants (ACTUAL) |
| Registered Start Date | 2022-07-07 |
| WhyStopped Classification | Lack of Efficacy / Futility |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| University of Arkansas for Medical Sciences | Little Rock, AR | Open Hospital Dossier -> |
| City of Hope National Medical Center | Duarte, CA | Open Hospital Dossier -> |
| UCI Health and Chao Family Comprehensive Cancer Center | Orange, CA | Open Hospital Dossier -> |
| Moffitt Cancer Center | Tampa, FL | Open Hospital Dossier -> |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Gilead Sciences across sibling Meru public-data platforms.
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.